Recro Pharma
REPH
$2.09
Share price
-0.48%
Change (1 day)
-28.42%
Change (1 year)
Categories
Revenue for Recro Pharma (REPH)
Revenue in 2021 (TTM): $75.36 M
According to Recro Pharma 's latest financial reports the company's current revenue (TTM) is $75.36 M. In 2020 the company made a revenue of $66.49 M a decrease over the years 2019 revenue that were of $99.21 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Recro Pharma from 2016 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $75.36 M | 13.33% |
| 2020 | $66.49 M | -32.98% |
| 2019 | $99.21 M | 28.28% |
| 2018 | $77.34 M | 7.67% |
| 2017 | $71.83 M | 3.6% |
| 2016 | $69.33 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 123,336.84% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $0.67 B | 795.67% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.10 B | 33.23% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $0.65 M | -99.14% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $20.96 M | -72.18% | 🇺🇸 USA |